Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria (Q29614408)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

review article

1 reference

title

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria (English)

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17616482

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Steven T. DeKosky

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

John T. O'Brien

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Florence Pasquier

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Martin Rossor

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Yaakov Stern

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

19

Philip Scheltens

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

6

Jeffrey Cummings

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

8

Douglas Galasko

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

3

Claudia Jacova

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

7

André Delacourte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

11

Kenichi Meguro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

16

Steven Salloway

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

9

Serge Gauthier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Bruno Dubois

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Pascale Barberger-Gateau

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Gregory Jicha

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Philippe Robert

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Pieter J Visser

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17616482

1 January 2020

language of work or name

1 reference

30 April 2017

publication date

1 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17616482

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

6

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17616482

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

734-746

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

8

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17616482

30 April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Amnestic MCI or prodromal Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Aging-Associated Cognitive Decline

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Mild cognitive impairment in the elderly: predictors of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Incidence and outcome of mild cognitive impairment in a population-based prospective cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Clinicopathologic correlates in Alzheimer disease: assessment of clinical and pathologic diagnostic criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Slowly progressive aphasia without generalized dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Corticodentatonigral Degeneration With Neuronal Achromasia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Corticobasal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Posterior cortical atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Frontotemporal dementia: clinicopathological correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Frontotemporal lobar degeneration and ubiquitin immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Editorial: advances in Alzheimer therapy: something old, something new, something borrowed, something blue.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Clinical trials in mild cognitive impairment: lessons for the future

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Alzheimer's Association Research Roundtable Meeting on Mild Cognitive Impairment: what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Vitamin E and donepezil for the treatment of mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Mild cognitive impairment as a diagnostic entity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Mild Cognitive Impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Behavioral symptoms in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Detection and management of cognitive impairment in primary care: The Steel Valley Seniors Survey

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Screening for early dementia using memory complaints from patients and relatives.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

The prediction of Alzheimer disease. The role of patient and informant perceptions of cognitive deficits

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Subjective memory complaints in the elderly: depressive symptoms and future dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

A verbal memory test with high predictive accuracy for dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Memory impairment on free and cued selective reminding predicts dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Cognitive markers preceding Alzheimer's dementia in the healthy oldest old.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Questionable dementia: clinical course and predictors of outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Mild cognitive impairment: a cross-national comparison

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Verbal memory performance of patients with a first depressive episode and patients with unipolar and bipolar recurrent depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Memory impairment differs in frontotemporal dementia and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Diagnosis of early dementia by the Double Memory Test: encoding specificity improves diagnostic sensitivity and specificity.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Memory evaluation with a new cued recall test in patients with mild cognitive impairment and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Memory function in very early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

The spectrum of behavioral changes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Volumetric MRI measurements can differentiate Alzheimer's disease, mild cognitive impairment, and normal aging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity, and analysis of the incorrectly classified subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Hippocampal atrophy in Alzheimer disease: age matters.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

MRI measures and progression of cognitive decline in nondemented elderly attending a memory clinic.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

MRI of entorhinal cortex in mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Hippocampal atrophy in normal aging. An association with recent memory impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

The amygdala and intractable temporal lobe epilepsy: a quantitative magnetic resonance imaging study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

MRI evidence of bilateral hippocampal sclerosis in amnestic mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

CSF markers for incipient Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

CSF biomarkers for mild cognitive impairment and early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Diagnosing prodromal Alzheimer's disease: role of CSF biochemical markers.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Safety and acceptability of the research lumbar puncture.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Positron emission tomography diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Alzheimer disease: operating characteristics of PET--a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Sensitivity and specificity of positron emission tomography and magnetic resonance imaging studies in Alzheimer's disease and multi-infarct dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

SPECT perfusion imaging in the diagnosis of Alzheimer's disease: a clinical-pathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Systematic Review of the Diagnostic Accuracy of 99mTc-HMPAO-SPECT in Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Genetic factors in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Inflammation, autotoxicity and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Hippocampal volume reduction in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

The effect of APOE genotype on clinical phenotype in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970178-3

7 January 2021

10.1016/S1474-4422(07)70178-3

Identifiers

DOI

3 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17616482

30 April 2017

Consolidated OpenCitations Corpus – April 2017

123010

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17616482%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

123010

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=17616482

3 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

123010